He said that they didn't need to do that at this time because there were/are other options available to them. 

Just for the record he said "I don't think we're missing out on anything there..."

I am still in shocked about this response.   He needs to be told there is 100-500 times more risk money looking for RVX type opportunities down there.   Don often pointed to multi-billion dollar valuations ($6-$13 B) of drug companies who's CVD drugs turned out to fail in Phase 3s.  I guess he didn't notice that every signle one of those companies were US listed.  I can't beleive the wealth we are all giving away because of the give-away share prices we endure (in PPs etc) because we remain so obscure in the great white north backwoods with minimal investment community promotion.  Its all behind our inability to fund further trials and control our own destiny and it is just plain sad that Big Pharma isn't being convinced we are worthy even with our FDA BTD in a brand new science we supposedly still have an eight year lead in.   Why aren't multiple BPs ramming down our door?  Any buy out offer that exceeds our market cap has to be announced.  Can it be that no BP has offered more than our pathetic $200M market cap?  Something that would have to be announced.  A recent analysis suggested that we are sitting on something that is worth minimum $8.3 Billion US -- that's 53 times greater value than our current market cap!  

How can this failure to gain even a remotely respectable valuation continue to be ignored!?  How can the CEO say not listing in the U.S. is like 'not missing out on anything'?  Someone help me with this!